Professional Documents
Culture Documents
Myelodysplastic Syndrome
Myelodysplastic Syndrome
Myelodysplastic Syndrome
Group of clonal disorders of hematopoietic
stem cells characterized by cellular
dysplasia and ineffective hematopoiesis
Results in cytopenias and dysmyelopoiesis
Variable risk of transformation to acute
leukemia
Pathophysiology
Primary MDS or Secondary MDS
A clonal mutation in hematopoietic stem cells
Bone marrow failure due to ineffective
hematopoiesis
Increased cytokines (TNF-a) inhibit
hematopoiesis
Increased apoptosis
Results in futile cycling of blood cells with
impaired production of mature blood cells
Prevalence
Mainly a disorder of older patients, rarely
presents before age 50
Median age is 65 years
Male predominance
Clinical Presentation
Non specific signs and symptoms of various
cytopenias
• Fatigue, SOB, exercise intolerance, pallor,
tachycardia
• Mucosal bleeding, petechiae, ecchymoses
• Infection, fever
Peripheral changes
include oval
macrocytic red cells,
hypogranular
granulocytes with the
pseudo-Pelger–Huët
anomaly, and giant
platelets.
Morphology
Megaloblastic red-cell
precursors with
multiple nuclei or
asynchronous
maturation of the
nucleus and the
cytoplasm
Morphology
Ringed sideroblasts,
erythroid precursors
with iron-laden
mitochondria
Classification
Disease Peripheral Blood Bone Marrow